Gedeon Richter Investment In Formycon Opens Up Collaboration Opportunities

Firm Takes 9% Stake In German Biosimilars Developer, Which Receives Over €80m

 
• By David Wallace
  
business investment
Gedeon Richter’s investment will help fund Formycon’s biosimilar development • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business